ASSESSMENT OF CLINICAL PROFILE AND TREATMENT CHART REVIEW FOR ALCOHOLIC LIVER DISEASE (ALD) PATIENTS: A PROSPECTIVE AND OBSERVATIONAL STUDY
Assessment of Alcoholic Liver Disease
Abstract
Background/Aim: Alcohol remains one of most common cause of liver disease in India, hence the present study was undertaken to assess the clinical profile and treatment chart review of alcoholic liver disease (ALD) patients.
Materials and Methods: Hospital based prospective and observational study was carried out for a period of nine months in a tertiary care hospital of south India. All the patients of either gender diagnosed with ALD were enrolled in the study and patient consent was taken, the data related to the patients of ALD were documented in a structured patient data collection form and analyzed carefully.
Results: ALD was mainly affected in male with age group of 41-50 years.Out of 130 patients 43.8% patients were suffered from Fatty Liver disease while 23.1% were suffered from Alcoholic Hepatitis and 33.1% were suffered from Cirrhosis of Liver. The secondary developments to ALD were portal hypertension (13.8%) followed by Ascities (10.8%) and Hepatitis (10%). The major risk factors involved in ALD was alcohol per se (52.3%) and, alcohol and smoking exaggerate the disease condition. The Periodic (61.5%) and regular basis (38.5%) of alcoholism for chronic period of time may land up with ALD. Polypharmacy is essential for the treatment of ALD as it inoved multiple secondary development to ALD. The patients were intervened and counselled on their individual basis for ALD consequences, and motivated for cessation of alcohol and smoking.
Conclusion: The study enlightens that the early diagnosis and its beneficial outcomes that can exponentially curtail the mortality rate of ALD. Similarly the optimal drug therapy regimen and patient counseling may improve the patient’s quality of life.
Keywords: Alcoholic Liver Disease; Optimal Drug Therapy; Patient Counselling; Improved Quality of Life
DOI
https://doi.org/10.22270/jddt.v8i5.1945References
Frazier TH, Stocker AM, Kershner NA, Marsano LS, Mclain CJ. Treatment of alcoholic liver disease. Therapeutic Advances in Gastroenterology 2011; 4(1):63-81.
World Health Organization. WHO status report on alcohol 2011. 2011. Available at:http://www.who.int/substance_abuse/publications/global_alcohol_report/msbgsruprofiles.pdf?ua=1. Last accessed:18 November 2015.
Cirrhosis National Institute of Diabetes and Digestive and Kidney Diseases NIH.2014; 1114-1134.
Suthar H, Suthar K, Mewada B. Clinical Profiles of cases of Alcoholic Liver Disease.2013; 2:408-412.
The evidence base for alcohol guidelines, Royal College of Physicians 2011.
Marsano LS, Mendez C, Hill D , Barve S, McClain C J , Diagnosis and Treatment of Alcoholic Liver Disease and Its Complications. 2003; 27(3):247-256.
Ishii H, Horie Y, Yamagishi Y, Ebinuma H. Alcoholic Liver Disease and Its Relationship with Metabolic Syndrome, JMAJ 2010; 53(4):236–242.
Jamdadea VS, Malikb reddy CD, Ahkar MA, Kolatia SR, Prescription pattern of drugs and WHO prescribing indicators used in alcoholic liver disease in a tertiary care teaching hospital in north eastern INDIA. Int J Pharm Bio Sci., 2015; 6(4): 503 – 510.
Dugum M, Cullough AM. Diagnosis and Management of Alcoholic Liver Disease, Journal of Clinical and Translational Hepatology. 2015; 3:109–116.
Hogerzeil HV, Bimo, Ross-Degnan Det al. Field tests for rational drug use in twelve developing countries. Lancet 1993; 342(8884):1408-1410.
Published


How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).